MedTrace Logo

Streptococcus Pneumoniae Nasopharyngeal Carriage

NCT01485029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2026-03-27

No results posted yet for this study

Summary

Antibiotic consumption and antimicrobial resistance remain notoriously high in France, particularly among children below three years of age. In France, the pneumococcal conjugate vaccine was officially recommended for all children under two in 2003, and consequently changes occurred in Streptococcus pneumoniae serotype distribution. Bacterial carriage among children attending day-care centres may result from vaccine- and antibiotic-driven selective pressure with possible repercussions on the community.

Conditions

  • Nursery

Interventions

PROCEDURE

Nasopharyngeal (NP) aspirate

Nasopharyngeal (NP) aspirate with a small flexible canule to obtain NP swabs

Sponsors & Collaborators

  • Department of Clinical Research and Innovation

    lead OTHER

Principal Investigators

  • Christian PRADIER, PU-PH · Centre Hospitalier Universitaire de Nice

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Months
Max Age
4 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2013-03-18
Completion
2014-03-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01485029 on ClinicalTrials.gov